Guest Editor’s Profile

Profile Image

Dr. Priyank Purohit

Designation : Associate Professor

Affiliation : Associate Professor at HSPS (Himalayan School of Pharmaceutical Sciences) Swami Rama Himalayan University, Jollygrant Dehradun uttarakhand, India, 248001

Expertise: Polymer chemistry, Material chemistry, Medicinal chemistry.

Institution Profile Link : https://srhu.edu.in/himalayan-school-of-pharmaceutical-sciences/#!tabset_0=1

Offical Email :

Role: Guest Editor

Journal: Journal of Polymer & Composites

About Me

Associate Professor in Department of Pharmaceutical Sciences at
Associate Professor at HSPS (Himalayan School of Pharmaceutical Sciences) Swami Rama Himalayan University, Jollygrant Dehradun, uttarakhand, India
My expertise are Polymer chemistry, Material chemistry, Medicinal chemistry.


Recent Publications

  1. Kailkhura, S., Purohit, P., Bhatt, A. et al. Eclipsed conformational locking: exploring iota carrageenan’s distinct behavior in ethanol–water systems via hydrogen bonding with thedisulfate group. Chem. Pap. (2024). https://doi.org/10.1007/s11696-024-03590-4. SCI Impact Factor-2.1.)
  2. A. Bhatt, S. Kailkhura, A. Shukla, S. Kumar, P. Purohit, M H. Abdellattif, Modulating Ionic Linkages in the Heterocyclic Sulfated Polysaccharide Carrageenan for Enhanced Selectivity Against Amelanotic Melanoma Cells. Chemistry Select, May 2024, 9, 20, https://doi.org/10.1002/slct.202400185 (SCI Impact Factor-1.9.)
  3. Shukla, A., Kumar, S., Bhatt, Purohit Priyank. Conversion of iota carrageenan hydrocolloids to hydrophobic hydrocolloids, by the replacement of potassium to barium ion, for the entrapment of water insoluble drugs. Discov Appl Sci 6, 244 (2024). https://doi.org/10.1007/s42452-024-05925-y (SCI Impact Factor-2.3. Q2)
  4. Rana V, Ghosh S, Bhatt A, et al. N-Methyl-D-Aspartate (NMDA) Receptor Antagonists and Their Pharmacological Implication: A Medicinal Chemistry-Oriented Perspective Outline.Current Medicinal Chemistry. 2024 Apr. DOI: 10.2174/0109298673288031240405061759. PMID: 38638036. (SCI Impact Factor-4.1. Q2)